Cost-effectiveness analysis of breast cancer screening by mammography in average-risk women in China

Main Article Content

Xudong Chen



Breast cancer is the most common form of cancer among women worldwide and is often at an advanced stage when clinical diagnosis. Fortunately, mammography could increase the detection rate of early-stage breast cancer. In this study, we conducted a cost-effectiveness analysis of breast cancer screening compared with no screening for average-risk women aged 45-69 every two years in China. Parameters about screening, costs, and utilities were taken from previous studies. Compared with no screening, mammography screening cost $1566.12 more with a reduction of 0.0088 QALYs (Quality-Adjusted Life Years), which was absolutely dominant. In summary, breast cancer screening by mammography was more recommended to high-risk women rather than average-risk women in China.


Download data is not yet available.

Article Details

Xudong Chen. (2023). Cost-effectiveness analysis of breast cancer screening by mammography in average-risk women in China. Advances in Women’s Health, 001–004.

Copyright (c) 2023 Chen X

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]


'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0





The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

He J, Chen W, Li N, Shen H, Li J, Wang Y. China Guideline for the Screening and Early Detection of Female Breast Cancer (2021, Beijing). China Cancer. 2021; 30(03):161-91.

Shen S, Sun Q, Huang X, Li Y, Li Y, Niu Z. Breast cancer screening guideline for Chinese women (version 2022). Chinese Research Hospitals. 2022; 9(02):6-13. doi: 10.19450/j.cnki.jcrh.2022.02.003.

The Society of Breast Cancer, China Anti-Cancer Association. Screening and early diagnosis of breast cancer in China: a practice guideline. China Oncology. 2022; 32(04):363-72. doi: 10.19401/j.cnki.1007-3639.2022.04.010.

Sun L, Legood R, Sadique Z, Dos-Santos-Silva I, Yang L. Cost-effectiveness of risk-based breast cancer screening programme, China. Bull World Health Organ. 2018 Aug 1;96(8):568-577. doi: 10.2471/BLT.18.207944. Epub 2018 Jun 28. PMID: 30104797; PMCID: PMC6083393.

American College of Radiology, BI-RADS Fifth Edition 2013.

National Cancer Center, Disease Prevention and Control Bureau Ministry of Health. Chinese Cancer Registry Annual Report.

Sun L, Sadique Z, Dos-Santos-Silva I, Yang L, Legood R. Cost-effectiveness of breast cancer screening programme for women in rural China. Int J Cancer. 2019 May 15;144(10):2596-2604. doi: 10.1002/ijc.31956. Epub 2018 Dec 8. PMID: 30367451.

Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000 Jun 15;151(12):1158-71. doi: 10.1093/oxfordjournals.aje.a010166. PMID: 10905528.

SEER Program. Division of Cancer Prevention and Control SP, Cancer Statistics Branched [Internet]. Bethesda: National Cancer Institute; 2002.

Sun L, Legood R, Yang L. Economic evaluation of ultrasonography and mammography for breast cancer screening among women in China. Chinese Journal of Health Policy. 2017; 10(04):42-50.

Wu L, Chen G, Ma Y, Li T, Xia J, Liu G. Analysis of breast cancer screening status among women aged 35-64 years in Guangdong Province in 2021. Chinese Journal of Woman and Child Health Research. 2023; 34(07):51-8.

Two cancers’ screening for rural women Project Management plan. Beijing: National Health and Family Planning Commission of the People’s Republic of China, 2015.

Zhang X. Screening Analysis and Health Economics Evaluation of Female Breast Cancer in Hebei Province [Master] 2021.

Gao Y. Development and Health Economic Evaluation of Breast Cancer Screening Strategy among Chinese Women [Doctor] 2016.

Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002 Oct;225(1):165-75. doi: 10.1148/radiol.2251011667. PMID: 12355001.

Hofer F, Kauczor HU, Stargardt T. Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: A modelling approach. Lung Cancer. 2018 Oct;124:189-198. doi: 10.1016/j.lungcan.2018.07.036. Epub 2018 Jul 24. PMID: 30268459.

Griffin E, Hyde C, Long L, Varley-Campbell J, Coelho H, Robinson S, Snowsill T. Lung cancer screening by low-dose computed tomography: a cost-effectiveness analysis of alternative programmes in the UK using a newly developed natural history-based economic model. Diagn Progn Res. 2020 Dec 2;4(1):20. doi: 10.1186/s41512-020-00087-y. PMID: 33292800; PMCID: PMC7709236.

Zhang T, Chen X, Li C, Wen X, Lin T, Huang J, He J, Zhong N, Jiang J, Liang W. Cost-Effectiveness Analysis of Risk Factor-Based Lung Cancer Screening Program by Low-Dose Computer Tomography in Current Smokers in China. Cancers (Basel). 2023 Sep 6;15(18):4445. doi: 10.3390/cancers15184445. PMID: 37760416; PMCID: PMC10527380.